First Drug for Lupus in 50 Years Released Passed Approval Wednesday

.

First Drug for Lupus in 50 Years Released Passed Approval Wednesday

On Wednesday the Food and Drug Administration announced its approval of a drug designed for the treatment of lupus; the first of its kind to hit the market in more than 50 years. The drug, called Benlysta, helps manage the symptoms of lupus, an immune disease that attacks the organs of the body. The drug works by restraining the bodily protein B-lymphocyte stimulator which causes the creating of auto antibodies when it reaches elevated levels. The auto antibodies attack healthy skin, kidney, heart and joint cells. “We expect to have this novel therapy available to physicians and patients within about two weeks, and our entire organization looks forward to the positive impact we hope this new therapy will have for patients with systematic lupus”, said H. Thomas Watkins on Wednesday.

The drug was developed in a partnership between Human Genome Sciences of Rockville and GlaxoSmithKline.

As expected, the approval of the drug led to a spike in stock prices for the developing organizations and Glaxo’s shares were up by close to 4% after hours.

The negative side of the drug is that the price of it is in the neighborhood of $35,000 each year for one patient. This is a huge price tag, equal or greater than the yearly salaries of many individuals. The only way they could even hope to afford this drug is to find a beneficiary with lots of money willing to pay for their treatment, or to gain approval for a claim for the medication by their health insurance company.

In addition, a panel of external medical experts was concerned about the small amount of safety data available on the drug and questioned its safety for use by African-American patients. The FDA itself admitted to the fact that African Americans didn’t respond very well to the treatments and that additional research would be needed to conclude how the use of the drug could affect the people of this heritage.

It’s obvious that the discovery and acceptance of this drug is great news for lots of people, but I would have thought responsible researchers would explore the impact of such an expensive drug on people of all races before it was approved for mass usage. However, a treatment is better than no treatment at all.


Latest News

Californians Will Face Changes in Electricity Bill as PUC Gets Ready to Vote on
Increase in the Number of U.S. Oil Drilling Rigs Break the 29 Week Successive De
Though Employers Hire at Steady Rate Wages Remain Flat
Aetna Acquiring Medicare Insurer Humana for $37 Billion in Cash and Stock Combin
New Financial Worries Leave Greece Divided
Airlines Next on The Probe List of Justice Department’s Antitrust Division
Shutting Down the Wrong Engine Led to Crash of TransAsia Flight GE235 in Taiwan
Dominion’s Yorktown Oil Burning Unit to be Shut Down
Microsoft’s Monday Announcements; Agreement with AOL to Move Display Ads, Sells
Phil Knight, Nike’s Co-Founder will Leave the Chairman’s Post Next Year
In spite of Introducing Several Stimulus, China’s Economy Indicates Weakness
Puerto Rico’s Financial Problems Grow Further as Report Says It Can no Longer Me